What are the indications, dosing regimens, contraindications, and monitoring recommendations for growth hormone‑releasing hormone (GHRH) analogues such as sermorelin and tesamorelin in diagnostic testing and therapeutic use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 10, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the use of Tessermorelin (generic name: tesamorelin) in women, particularly those with human immunodeficiency virus (HIV)-associated lipodystrophy or growth hormone deficiency?

Can tesamorelin (growth hormone-releasing factor) worsen cardiomyopathy?

Can tesamorelin (growth hormone-releasing factor) cause hypertension?

Does tesamorelin (growth hormone-releasing factor) cause skin thickening?

What is the treatment for an adult HIV patient with lipodystrophy using Egrifta (tesamorelin)?

What is the appropriate diagnostic work‑up for an adult patient presenting with bright red bloody stools?

What is the appropriate management of an incidentally discovered 3 mm calcified pulmonary granuloma on a routine chest X‑ray in an asymptomatic patient with no known risk factors?

How should I evaluate and manage a teenage girl with duodenogastric bile reflux presenting with nausea, epigastric discomfort, bitter‑tasting vomitus, and early satiety?

In a 60‑70‑year‑old man with diabetes mellitus, hypertension, obesity (BMI 31) and a smoking history (quit 15 years ago) presenting with difficulty walking short distances, what is the primary risk factor for his symptoms?

How should I manage an adult patient with basal infiltrates and reduced aeration on chest X‑ray that could represent early atelectasis versus community‑acquired pneumonia?

What is the recommended management for chronic non‑infectious iriditis in an adult patient, including topical corticosteroids, cycloplegics, intra‑ocular pressure monitoring, and indications for systemic steroids or immunomodulatory therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.